SEC Form 4 research
| Issuer | Vaxcyte, Inc. |
|---|---|
| Tickers | PCVX |
| Reporting owners | 38 |
| Officers and directors | 14 |
| Last public filing | 2026-11-04 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-04 | 2026-11-02 | Cowan Elvia | S | 586 | $61.55 | Not reported |
| 2026-11-04 | 2026-11-02 | Cowan Elvia | S | 2,414 | $60.77 | Not reported |
| 2026-11-04 | 2026-11-02 | Wassil Jim | S | 343 | $61.57 | Not reported |
| 2026-11-04 | 2026-11-02 | Wassil Jim | S | 1,907 | $60.78 | Not reported |
| 2026-10-07 | 2026-10-05 | Wassil Jim | S | 18,000 | $86.74 | Not reported |
| 2026-10-07 | 2026-10-05 | Cowan Elvia | S | 19,000 | $86.74 | Not reported |
| 2026-10-02 | 2026-10-01 | Wassil Jim | S | 95 | $57.09 | Not reported |
| 2026-10-02 | 2026-10-01 | Wassil Jim | S | 2,155 | $56.65 | Not reported |
| 2026-09-09 | 2026-09-09 | Wassil Jim | S | 1,334 | $59.52 | Not reported |
| 2026-09-09 | 2026-09-04 | Wassil Jim | S | 1,381 | $61.16 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.